Registries on peritoneal surface malignancies throughout the world, their use and their options

References

• Sugarbaker PH. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of gastrointestinal cancers with peritoneal metastases: Progress toward a new standard of care. Cancer Treat Rev 48:42–9.
   PubMed Web of Science ®Google Scholar
• Loggie BW, Thomas P. (2015). Gastrointestinal cancers with peritoneal carcinomatosis: surgery and hyperthermic intraperitoneal chemotherapy. Oncology (Williston Park) 29:515–21.
   PubMed Web of Science ®Google Scholar
• Witkamp AJ, de Bree E, Kaag MM, et al. (2001). Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37:979–84.
   PubMed Web of Science ®Google Scholar
• Cavaliere F, Valle MD, Simone M, et al. (2006). 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study. In Vivo 20(6A):747–50.
   Web of Science ®Google Scholar
• Ceelen WP. (2005). Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin. Surg Technol Int 14:125–30.
   PubMedGoogle Scholar
• Elias D, Pocard M, Goere D. (2007). HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat Res 134:303–18.
   PubMedGoogle Scholar
• Mirnezami R, Mehta AM, Chandrakumaran K, et al. (2014). Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer 111:1500–8.
   PubMed Web of Science ®Google Scholar
• Moran BJ, Meade B, Murphy E. (2006). Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients. Colorectal Dis 8:544–50.
   PubMed Web of Science ®Google Scholar
• Piso P, Dahlke MH, Ghali N, et al. (2007). Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis 22:1295–300.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. (2003). Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–43.
   PubMed Web of Science ®Google Scholar
• Razenberg LG, Lemmens VE, Verwaal VJ, et al. (2016). Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: results of a population-based study. Eur J Cancer 65:113–20.
   PubMed Web of Science ®Google Scholar
• Rouers A, Laurent S, Detroz B, Meurisse M. (2006). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: higher complication rate for oxaliplatin compared to Mitomycin C. Acta Chir Belg 106:302–6.
   PubMed Web of Science ®Google Scholar
• Smeenk RM, Verwaal VJ, Zoetmulder FA. (2006). Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei–a report of 103 procedures. Eur J Surg Oncol 32:186–90.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. (2004). Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85:61–7.
   PubMed Web of Science ®Google Scholar
• Mehta SS, Gelli M, Agarwal D, Goere D. (2016). Complications of cytoreductive surgery and hipec in the treatment of peritoneal metastases. Indian J Surg Oncol 7:225–9.
   PubMed Web of Science ®Google Scholar
• Newton AD, Bartlett EK, Karakousis GC. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol 7:99–111.
   PubMed Web of Science ®Google Scholar
• Wallet F, Maucort Boulch D, Malfroy S, et al. (2016). No impact on long-term survival of prolonged ICU stay and re-admission for patients undergoing cytoreductive surgery with HIPEC. Eur J Surg Oncol 42:855–60.
   PubMed Web of Science ®Google Scholar
• Razenberg LG, van Gestel YR, Creemers GJ, et al. (2015). Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. Eur J Surg Oncol 41:466–71.
   PubMed Web of Science ®Google Scholar
• Kuijpers AM, Mirck B, Aalbers AG, et al. (2013). Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol 20:4224–30.
   PubMed Web of Science ®Google Scholar
• Glehen O, Gilly FN, Arvieux C, et al. (2010). Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370–7.
   PubMed Web of Science ®Google Scholar
• Esquivel J, Lowy AM, Markman M, et al. (2014). The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with colorectal cancer with peritoneal carcinomatosis. Ann Surg Oncol 21:4195–201.
   PubMed Web of Science ®Google Scholar
• Mohamed F, Moran BJ. (2009). Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J 15:196–9.
   PubMed Web of Science ®Google Scholar
• Kuijpers AM, Hauptmann M, Aalbers AG, et al. (2016). Cytoreduction and hyperthermic intraperitoneal chemotherapy: the learning curve reassessed. Eur J Surg Oncol 42:244–50.
   PubMed Web of Science ®Google Scholar
• Arakelian E, Gunningberg L, Larsson J, et al. (2011). Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 37:897–903.
   PubMed Web of Science ®Google Scholar
• Villeneuve L, Passot G, Glehen O, et al. (2017). The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry. Orphanet J Rare Dis 12:37.
   PubMed Web of Science ®Google Scholar
• Pelz JO, Doerfer J, Dimmler A, et al. (2006). Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. BMC Cancer 6:162.
   PubMed Web of Science ®Google Scholar
• Hompes D, D'Hoore A, Van Cutsem E, et al. (2009). Evaluation of the treatment of peritoneal carcinomatosis of colorectal cancer (CRC) with complete cytoreduction and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: A Belgian multicenter prospective phase II clinical study. J Clin Oncol 27(15_suppl):4101.
   Web of Science ®Google Scholar
• Elias D, Goere D, Blot F, et al. (2007). Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14:1818–24.
   PubMed Web of Science ®Google Scholar
• Detroz B, Laurent S, Honore P, et al. (2004). Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis. Acta Chir Belg 104:377–83.
   PubMed Web of Science ®Google Scholar
• Villeneuve L, Isaac S, Glehen O, et al. (2014). [The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists]. Ann Pathol 34:4–8.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Baratti D, Hutanu I, et al. (2012). The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs. Surg Oncol Clin N Am 21:559–76.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Baratti D, Deraco M. (2012). Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg 255:348–56.
   PubMed Web of Science ®Google Scholar